Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$937M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$662M |
| 4 |
iShares MSCI United Kingdom ETF
EWU
|
+$615M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$541M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$717M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$633M |
| 4 |
SPDR Gold Trust
GLD
|
+$617M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.47% |
| 2 | Consumer Discretionary | 2.1% |
| 3 | Financials | 1.38% |
| 4 | Communication Services | 1.28% |
| 5 | Healthcare | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCRN
5151
DELISTED
Cross Country Healthcare
CCRN
| $862K | ﹤0.01% |
38,605
-19,390
| -33% | -$508K |
|
5152
CALL
Mattel
MAT
$4.19B
| $862K | ﹤0.01% |
46,800
-273,300
| -85% | -$5.08M |
|
5153
CALL
Dillards
DDS
$9.93B
| $862K | ﹤0.01% |
2,800
-9,300
| -77% | -$3.31M |
|
5154
CALL
Neurocrine Biosciences
NBIX
$15.9B
| $860K | ﹤0.01% |
8,500
-59,900
| -88% | -$6.23M |
|
5155
DHT Holdings
DHT
$3.01B
| $860K | ﹤0.01% |
79,538
+66,452
| +508% | +$668K |
|
5156
PUT
Alliant Energy
LNT
$18.2B
| $860K | ﹤0.01% |
+16,100
| New | +$856K |
|
5157
PUT
Invesco
IVZ
$13.9B
| $859K | ﹤0.01% |
52,400
-55,800
| -52% | -$996K |
|
5158
Cabaletta Bio
CABA
$465M
| $858K | ﹤0.01% |
103,791
+63,757
| +159% | +$597K |
|
|
PLAT
5159
DELISTED
WisdomTree Growth Leaders Fund
PLAT
| $858K | ﹤0.01% |
29,340
+4,176
| +17% | +$116K |
|
5160
AdvisorShares Dorsey Wright ADR ETF
AADR
$38.9M
| $858K | ﹤0.01% |
17,957
+9,163
| +104% | +$444K |
|
5161
Standard Motor Products
SMP
$877M
| $857K | ﹤0.01% |
+23,230
| New | +$884K |
|
5162
SEACOR Marine Holdings
SMHI
$264M
| $857K | ﹤0.01% |
112,609
+98,754
| +713% | +$939K |
|
5163
Kura Oncology
KURA
$882M
| $856K | ﹤0.01% |
69,991
+58,702
| +520% | +$733K |
|
5164
DXC Technology
DXC
$1.71B
| $855K | ﹤0.01% |
33,469
-127,134
| -79% | -$3.47M |
|
5165
Ingredion
INGR
$6.54B
| $855K | ﹤0.01% |
8,403
+3,891
| +86% | +$388K |
|
5166
Ponce Financial Group
PDLB
$500M
| $854K | ﹤0.01% |
108,787
+97,726
| +884% | +$885K |
|
5167
ClearShares OCIO ETF
OCIO
$172M
| $854K | ﹤0.01% |
+29,675
| New | +$850K |
|
5168
PUT
Worthington Enterprises
WOR
$2.78B
| $853K | ﹤0.01% |
+21,410
| New | +$757K |
|
5169
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund
FDTS
$14M
| $853K | ﹤0.01% |
21,326
-2,831
| -12% | -$112K |
|
5170
CALL
Kymera Therapeutics
KYMR
$9.48B
| $853K | ﹤0.01% |
28,800
+13,700
| +91% | +$442K |
|
5171
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
| $853K | ﹤0.01% |
9,604
-17,784
| -65% | -$1.63M |
|
5172
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$844M
| $852K | ﹤0.01% |
17,029
-40,016
| -70% | -$1.99M |
|
5173
CALL
Agios Pharmaceuticals
AGIO
$2.04B
| $852K | ﹤0.01% |
37,100
-54,000
| -59% | -$1.43M |
|
|
TSP
5174
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $851K | ﹤0.01% |
+578,963
| New | +$1.1M |
|
|
INFN
5175
DELISTED
Infinera Corporation Common Stock
INFN
| $851K | ﹤0.01% |
109,633
+53,783
| +96% | +$391K |
|
Similar funds
Jane Street's Q1 2023 Portfolio in Review
As of Q1 2023, Jane Street held 10,675 positions worth $244B, up 13% from $216B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street's Q1 2023 filing shows 1,657 new, 3,180 increased, 3,974 reduced and 1,760 closed positions. Its largest new stake was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jane Street's largest Q1 2023 buy was iShares MSCI EAFE Value ETF: 11,182,830 shares worth $543M.
- Jane Street added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2023, an estimated $1.29B increase.
- Jane Street's biggest Q1 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $1.06B.
- Jane Street fully exited State Street SPDR Bloomberg Convertible Securities ETF in Q1 2023, selling an estimated $119M.
- Jane Street's ten largest holdings make up 36% of its $244B portfolio in Q1 2023.
- Jane Street opened 1,657 new positions and closed 1,760 in Q1 2023.
- Jane Street's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.